Log In
Print
BCIQ
Print
Print this Print this
 

Thyroid receptor beta agonist (VK0214) (formerly LG0956965)

  Manage Alerts
Collapse Summary General Information
Company Ligand Pharmaceuticals Inc.
DescriptionLiver-selective thyroid hormone receptor beta agonist
Molecular Target Thyroid hormone receptor beta
Mechanism of ActionThyroid hormone receptor beta agonist
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationDyslipidemia
Indication DetailsTreat dyslipidemia
Regulatory Designation
Partner Viking Therapeutics Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$1,531.5M

0

$1,500.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today